sub:assertion {
d:DB00363 v:identifier "DB00363" ;
v:namespace "drugbank" ;
v:uri "http://bio2rdf.org/drugbank:DB00363" ;
v:x-identifiers.org <
http://identifiers.org/drugbank/DB00363> ;
dv:drugbank-id "APRD00470" , "DB00363" ;
dv:x-ahfs <
http://bio2rdf.org/ahfs:28:16.08.04> ;
dv:x-atc <
http://bio2rdf.org/atc:N05AH02> ;
dv:x-bindingdb <
http://bio2rdf.org/bindingdb:22869> ;
dv:x-cas <
http://bio2rdf.org/cas:5786-21-0> ;
dv:x-chebi <
http://bio2rdf.org/chebi:3766> ;
dv:x-chemspider <
http://bio2rdf.org/chemspider:2716> ;
dv:x-dpd <
http://bio2rdf.org/dpd:2240669> ;
dv:x-gtp <
http://bio2rdf.org/gtp:38> ;
dv:x-iuphar <
http://bio2rdf.org/iuphar:38> ;
dv:x-kegg <
http://bio2rdf.org/kegg:C06924> , <
http://bio2rdf.org/kegg:D00283> ;
dv:x-ndc <
http://bio2rdf.org/ndc:57664-345-88> ;
dv:x-pharmgkb <
http://bio2rdf.org/pharmgkb:PA449061> ;
dv:x-pubchemcompound <
http://bio2rdf.org/pubchem.compound:2818> ;
dv:x-pubchemsubstance <
http://bio2rdf.org/pubchem.substance:46506474> ;
dv:x-wikipedia <
http://bio2rdf.org/wikipedia:Clozapine> ;
dct:description "A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. [PubChem]"@en ;
dct:identifier "drugbank:DB00363" ;
dct:title "Clozapine"@en ;
a dv:Drug ;
rdfs:label "Clozapine [drugbank:DB00363]"@en ;
rdfs:seeAlso <
http://www.drugbank.ca/drugs/DB00363> , <
http://www.drugs.com/clozapine.html> , <
http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/clo1089.shtml> , <
http://www.rxlist.com/cgi/generic3/clozapine.htm> .
}